Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

1.8K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.8K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

2.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

3.2K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.2K
Chemical Synapses01:26

Chemical Synapses

12.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.1K
Chemical Synapses01:26

Chemical Synapses

4.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.8K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Work-related stressful events and burnout experienced by residents and specialists in German neurology: prevalence, causes, and coping strategies derived from a nationwide survey.

Neurological research and practice·2025
Same author

Laughing Gas-Induced Funicular Myelopathy.

Deutsches Arzteblatt international·2025
Same author

Correction: Guideline "Transient Global Amnesia (TGA)" of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): S1-guideline.

Neurological research and practice·2023
Same author

Guideline "Transient Global Amnesia (TGA)" of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): S1-guideline.

Neurological research and practice·2023
Same author

Spelling interface using intracortical signals in a completely locked-in patient enabled via auditory neurofeedback training.

Nature communications·2022
Same author

Bilateral Fascicular Third Nerve Palsy in Posterior Circulation Stroke.

Neuro-ophthalmology (Aeolus Press)·2019
Same journal

Anterior Cingulate Cortex Mediates State-Dependent Prioritization of Distressed Conspecifics.

Brain sciences·2026
Same journal

Hemispherotomy for Pediatric Post-Traumatic Epilepsy.

Brain sciences·2026
Same journal

When Robots Learn: Artificial Intelligence and the Next Human-Centered Era of Neurorehabilitation.

Brain sciences·2026
Same journal

The Association Between Changes in White Matter Microstructure and Cognitive Function in Older Adults with Mild Cognitive Impairment.

Brain sciences·2026
Same journal

Beyond Ventricular Enlargement: Multimodal MRI Assessment Improves Surgical Decision-Making in Normal Pressure Hydrocephalus.

Brain sciences·2026
Same journal

The Effects of Personalized Observation, Execution, and Mental Imagery (POEM) Therapy in Logopenic Primary Progressive Aphasia: A Telepractice-Based Single-Case Study.

Brain sciences·2026
See all related articles

Related Experiment Video

Updated: Feb 24, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.4K

Myoclonic Disorders.

Olaf Eberhardt1, Helge Topka2

  • 1Klinik für Neurologie, Klinikum Bogenhausen, Städt. Klinikum München GmbH, Englschalkinger Str. 77, 81925 München, Germany. olafeberhardt@web.de.

Brain Sciences
|August 15, 2017
PubMed
Summary
This summary is machine-generated.

Myoclonus, a complex movement disorder, presents diagnostic and treatment challenges. Recent advances illuminate its pathophysiology and genetics, offering new insights for pediatric and adult neurology.

Keywords:
encephalopathiesepilepsymovement disordersmyoclonusneurogenetics

More Related Videos

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
18:01

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

14.7K
Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
07:38

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

8.8K

Related Experiment Videos

Last Updated: Feb 24, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.4K
Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
18:01

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants

Published on: August 18, 2008

14.7K
Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats
07:38

Generating Acute and Chronic Experimental Models of Motor Tic Expression in Rats

Published on: May 27, 2021

8.8K

Area of Science:

  • Neurology
  • Genetics
  • Movement Disorders

Background:

  • Myoclonus presents a diagnostic and therapeutic challenge due to diverse causes and classifications.
  • Recent years have seen significant progress in understanding the pathophysiology and genetic underpinnings of myoclonic disorders.

Purpose of the Study:

  • To review key types of myoclonus in pediatric and adult neurology.
  • To highlight recent advancements in understanding myoclonus.
  • To present an updated list of the genetic basis for major myoclonic disorders.

Main Methods:

  • Literature review focusing on recent developments in myoclonus.
  • Compilation of current knowledge on pathophysiology and genetics.
  • Summary of diagnostic and therapeutic approaches.

Main Results:

  • Advances in understanding the pathophysiology and genetic basis of various myoclonic disorders.
  • An updated list of genetic causes for major myoclonic conditions.
  • Scarcity of randomized therapeutic studies, but pragmatic diagnostic and treatment strategies have been suggested.

Conclusions:

  • Recent research has deepened the understanding of myoclonus.
  • Despite limited randomized trials, practical approaches to diagnosis and treatment are emerging.
  • This review provides a comprehensive overview for clinicians managing myoclonic disorders.